These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 19029444
41. The ENL YEATS epigenetic reader domain critically links MLL-ENL to leukemic stem cell frequency in t(11;19) Leukemia. Hu H, Saha N, Yang Y, Ahmad E, Lachowski L, Shrestha U, Premkumar V, Ropa J, Chen L, Teahan B, Grigsby S, Marschalek R, Nikolovska-Coleska Z, Muntean AG. Leukemia; 2023 Jan; 37(1):190-201. PubMed ID: 36435883 [Abstract] [Full Text] [Related]
42. Generation and characterization of bioluminescent xenograft mouse models of MLL-related acute leukemias and in vivo evaluation of luciferase-targeting siRNA nanoparticles. Fazzina R, Lombardini L, Mezzanotte L, Roda A, Hrelia P, Pession A, Tonelli R. Int J Oncol; 2012 Aug; 41(2):621-8. PubMed ID: 22665135 [Abstract] [Full Text] [Related]
43. MLL-Rearranged Acute Leukemia with t(4;11)(q21;q23)-Current Treatment Options. Is There a Role for CAR-T Cell Therapy? Britten O, Ragusa D, Tosi S, Kamel YM. Cells; 2019 Oct 29; 8(11):. PubMed ID: 31671855 [Abstract] [Full Text] [Related]
44. Myeloid transformation by MLL-ENL depends strictly on C/EBP. Wesolowski R, Kowenz-Leutz E, Zimmermann K, Dörr D, Hofstätter M, Slany RK, Mildner A, Leutz A. Life Sci Alliance; 2021 Jan 29; 4(1):. PubMed ID: 33144337 [Abstract] [Full Text] [Related]
45. Differential requirement for wild-type Flt3 in leukemia initiation among mouse models of human leukemia. Kamezaki K, Luchsinger LL, Snoeck HW. Exp Hematol; 2014 Mar 29; 42(3):192-203.e1. PubMed ID: 24269847 [Abstract] [Full Text] [Related]
55. MLL-ENL causes a reversible and myc-dependent block of myelomonocytic cell differentiation. Schreiner S, Birke M, García-Cuéllar MP, Zilles O, Greil J, Slany RK. Cancer Res; 2001 Sep 01; 61(17):6480-6. PubMed ID: 11522644 [Abstract] [Full Text] [Related]
56. MLL chimeric protein activation renders cells vulnerable to chromosomal damage: an explanation for the very short latency of infant leukemia. Eguchi M, Eguchi-Ishimae M, Knight D, Kearney L, Slany R, Greaves M. Genes Chromosomes Cancer; 2006 Aug 01; 45(8):754-60. PubMed ID: 16688745 [Abstract] [Full Text] [Related]
57. MLL leukemia induction by genome editing of human CD34+ hematopoietic cells. Buechele C, Breese EH, Schneidawind D, Lin CH, Jeong J, Duque-Afonso J, Wong SH, Smith KS, Negrin RS, Porteus M, Cleary ML. Blood; 2015 Oct 01; 126(14):1683-94. PubMed ID: 26311362 [Abstract] [Full Text] [Related]